BRPI0407850A - processo para fabricação de uma composição farmacêutica contendo o princìpio ativo fenofibrato ou de um de seus derivados, e, comprimido de fenofibrato ou de um de seus derivados - Google Patents

processo para fabricação de uma composição farmacêutica contendo o princìpio ativo fenofibrato ou de um de seus derivados, e, comprimido de fenofibrato ou de um de seus derivados

Info

Publication number
BRPI0407850A
BRPI0407850A BRPI0407850-0A BRPI0407850A BRPI0407850A BR PI0407850 A BRPI0407850 A BR PI0407850A BR PI0407850 A BRPI0407850 A BR PI0407850A BR PI0407850 A BRPI0407850 A BR PI0407850A
Authority
BR
Brazil
Prior art keywords
derivatives
fenofibrate
active ingredient
manufacture
pharmaceutical composition
Prior art date
Application number
BRPI0407850-0A
Other languages
English (en)
Inventor
Jerome Besse
Original Assignee
Sarl Galenix Innovations
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sarl Galenix Innovations filed Critical Sarl Galenix Innovations
Publication of BRPI0407850A publication Critical patent/BRPI0407850A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"PROCESSO PARA A FABRICAçãO DE UMA COMPOSIçãO FARMACêUTICA CONTENDO O PRINCìPIO ATIVO FENOFIBRATO OU UM DE SEUS DERIVADOS, E, COMPRIMIDO DE FENOFIBRATO OU DE UM DE SEUS DERIVADOS". Processo para a fabricação de uma composição farmacêutica contendo o princípio ativo fenofibrato ou de um de seus derivados, eventualmente em associação com um segundo princípio ativo, sob a forma de comprimidos, caracterizado em que ele compreende uma etapa de compactação do princípio ativo e dos excipientes por granulação por via seca.
BRPI0407850-0A 2003-02-28 2004-02-27 processo para fabricação de uma composição farmacêutica contendo o princìpio ativo fenofibrato ou de um de seus derivados, e, comprimido de fenofibrato ou de um de seus derivados BRPI0407850A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0302520A FR2851734B1 (fr) 2003-02-28 2003-02-28 Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede
PCT/FR2004/050090 WO2004078108A2 (fr) 2003-02-28 2004-02-27 Comprime de fenofibrate et procede de fabrication

Publications (1)

Publication Number Publication Date
BRPI0407850A true BRPI0407850A (pt) 2006-03-14

Family

ID=32843093

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0407850-0A BRPI0407850A (pt) 2003-02-28 2004-02-27 processo para fabricação de uma composição farmacêutica contendo o princìpio ativo fenofibrato ou de um de seus derivados, e, comprimido de fenofibrato ou de um de seus derivados

Country Status (20)

Country Link
US (1) US20060177499A1 (pt)
EP (1) EP1601346B1 (pt)
JP (1) JP2006520770A (pt)
CN (1) CN100479808C (pt)
AT (1) ATE439125T1 (pt)
AU (1) AU2004216869B2 (pt)
BR (1) BRPI0407850A (pt)
CA (1) CA2517429C (pt)
DE (1) DE602004022515D1 (pt)
FR (1) FR2851734B1 (pt)
IL (1) IL170507A (pt)
MA (1) MA27662A1 (pt)
MX (1) MXPA05009113A (pt)
NO (1) NO20054417L (pt)
NZ (1) NZ542039A (pt)
PL (1) PL378106A1 (pt)
RU (1) RU2362547C2 (pt)
TN (1) TNSN05203A1 (pt)
WO (1) WO2004078108A2 (pt)
ZA (1) ZA200506992B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006273849A (ja) * 2005-03-02 2006-10-12 Aska Pharmaceutical Co Ltd フェノフィブラート含有組成物
US20090208576A1 (en) * 2006-03-31 2009-08-20 Gandhi Anilkumar S Orally Disintegrating Tablets
CN100577157C (zh) * 2006-07-12 2010-01-06 姚俊华 含有降血脂成分的分散片及其制备方法
CA2638240C (en) * 2008-08-29 2010-02-02 Alexander Macgregor Method of treating dysglycemia and glucose excursions
JP5452051B2 (ja) * 2009-03-27 2014-03-26 杏林製薬株式会社 イミダフェナシン含有口腔内崩壊錠
CN102675748A (zh) * 2012-05-22 2012-09-19 苏州新区华士达工程塑胶有限公司 一种耐候聚丙烯的配方
CN110325177A (zh) * 2017-02-20 2019-10-11 帝斯曼知识产权资产管理有限公司 生产包衣颗粒的方法
KR102271734B1 (ko) * 2020-10-21 2021-07-01 한국프라임제약주식회사 건식과립공정용 멀티비타민 약제학적 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
DE4414538A1 (de) * 1994-04-26 1995-11-02 Klinge Co Chem Pharm Fab Präparate zur Therapie der kombinierten Hyperlipidämie mit einem Gehalt an einem p-Oxybenzoesäurederivat und einem Fibrat
FR2730231B1 (fr) * 1995-02-02 1997-04-04 Fournier Sca Lab Association de fenofibrate et de vitamine e, utilisation en therapeutique
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
FR2758461A1 (fr) * 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
FR2774591B1 (fr) * 1998-02-12 2000-05-05 Lipha Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie
FR2781793B1 (fr) * 1998-08-03 2001-07-20 Prographarm Lab Procede de fabrication de granules de gabapentine enrobes
US6180138B1 (en) * 1999-01-29 2001-01-30 Abbott Laboratories Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
CA2407027C (en) * 2000-04-20 2011-02-15 Rtp Pharma Inc. Improved water-insoluble drug particle process
FR2819720B1 (fr) * 2001-01-22 2004-03-12 Fournier Lab Sa Nouveaux comprimes de fenofibrate
NZ527408A (en) * 2001-02-22 2005-04-29 Skyepharma Canada Inc Hydroxymethylglutarylcoenzyme A (HMG CoA) reductase inhibitor (or a statin) and a fibrate in a single effective oral dosage form to treat dyslipidaemia and dyslipoproteinaemia
EP1364646A4 (en) * 2001-03-01 2005-08-03 Grelan Pharmaceutical Co FENOFIBRATE CONTAINING COMPOSITION

Also Published As

Publication number Publication date
DE602004022515D1 (de) 2009-09-24
CA2517429A1 (fr) 2004-09-16
NZ542039A (en) 2008-08-29
PL378106A1 (pl) 2006-03-06
IL170507A (en) 2011-11-30
EP1601346A2 (fr) 2005-12-07
MXPA05009113A (es) 2006-05-31
ATE439125T1 (de) 2009-08-15
CA2517429C (fr) 2012-04-17
MA27662A1 (fr) 2005-12-01
WO2004078108A3 (fr) 2004-12-09
CN100479808C (zh) 2009-04-22
AU2004216869A1 (en) 2004-09-16
ZA200506992B (en) 2007-04-25
NO20054417L (no) 2005-09-23
FR2851734A1 (fr) 2004-09-03
EP1601346B1 (fr) 2009-08-12
FR2851734B1 (fr) 2006-06-09
RU2005130155A (ru) 2006-06-10
WO2004078108A2 (fr) 2004-09-16
CN1780606A (zh) 2006-05-31
AU2004216869B2 (en) 2009-05-14
JP2006520770A (ja) 2006-09-14
US20060177499A1 (en) 2006-08-10
TNSN05203A1 (fr) 2007-06-11
RU2362547C2 (ru) 2009-07-27

Similar Documents

Publication Publication Date Title
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
AR038527A1 (es) Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
HRP20090194T1 (hr) Suha granulirana kompozicija koja sadrži emtricitabin i tenofovir df
ATE374016T1 (de) Tablette mit hohem wirkstoffgehalt
ATE354362T1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
NO20043792L (no) New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
BRPI0412364A (pt) composição farmacêutica sólida, compreendendo amisulpride
BRPI0407850A (pt) processo para fabricação de uma composição farmacêutica contendo o princìpio ativo fenofibrato ou de um de seus derivados, e, comprimido de fenofibrato ou de um de seus derivados
BRPI0518789A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete
BRPI0518790A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete
AR048672A1 (es) Tabletas de desintegracion que comprenden licarbazepina
EA200801614A1 (ru) Фармацевтическая композиция, содержащая монтелукаст
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
SE0203817D0 (sv) New composition
AR053154A1 (es) Metodo de tratamiento y combinacion de roflumilast y un inhibidor de integrina
DK1499278T3 (da) Farmaceutisk doseringsform, som udviser umiddelbar frigivelse, og som omfatter polymorf tibolon
ITMI20020872A1 (it) Derivati dell'iperforina loro uso e formulazioni che li contengono
PA8579401A1 (es) Derivados de 2,3-dihidro-isoindol-1-ona como inhibidores de mao-b
ITUD20030196A1 (it) Procedimento per la preparazione di dosaggi farmaceutici contenenti molteplici principi attivi.
DK1759711T3 (da) Chitosan/siliciumdioxid.copræcipitat og anvendelse som excipiens i faste doseringsformer
PT1275383E (pt) Composicao farmaceutica de libertacao modificada que contem bupropion hc1 como substancia activa
SE0300830D0 (sv) New formulations and use thereof

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 9/14, 31/216, 9/20, 31/505, 31/70, 31/195, 31/365, 31/40, 31/405; A61P 3/06

Ipc: A61K 9/14 (2011.01), A61K 31/216 (2011.01), A61K 9

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2259 DE 22/04/2014.